Palo Alto Investors Sells Out Of Savient Pharmaceuticals

William Leland Edwards‘ fund, Palo Alto Investors, just reported cutting down its entire position in nano-cap company Savient Pharmaceuticals Inc (OTCMKTS:SVNTQ). In its latest 13F, Palo Alto revealed holding over 9.74 million shares of Savient.

Savient Pharmaceuticals Inc

Disclosure: none

Recommended Reading:

Phil Frohlich, Prescott Still Loading Up on China Marine Food Group

Hillhouse Capital Management Discloses New Stake in Qunar Cayman Islands

Noam Gottesman, GLG Partners Are Bullish on Tableau Software

Dividend Stock Alert - Billionaire Robbins' Top Dividend Idea With 70% Upside Potential

Get Paid 3.5% Per Year While Waiting For The Stock Appreciate 70%

Larry Robbins' Glenview Capital Opportunity Fund returned 101.7% in 2013 and Robbins personally made $750 million. The same fund returned 25.3% in 2014. In this FREE REPORT we will share Robbins' top dividend idea that yields 3.5% and has been increasing its dividends for 39 consecutive years. Robbins thinks the stock has the potential to appreciate 70%.

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Click Here to Read Comments
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!